PTGS2 and triple-negative breast carcinoma: For β-elemene, Su et al.66 found that β-elemene combined with 5-fluorouracil (5-FU) inhibited triple-negative breast cancer growth by interfering with the nuclear factor-kappaB (NF-κB)/PTGS2 pathway.